Global Male Infertility Market to Grow at a CAGR of 5.68%, 2017-2021 with ASKA Pharmaceutical, Halotech DNA, Merck Serono & Zydus Cadila Healthcare Leading the Market – Research and Markets

DUBLIN–(BUSINESS WIRE)–Research and Markets has announced the addition of the “Global
Male Infertility Market 2017-2021”
report to their offering.

The global male infertility market to grow at a CAGR of 5.68% during the
period 2017-2021.

The report, Global Male Infertility Market 2017-2021, has been prepared
based on an in-depth market analysis with inputs from industry experts.
The report covers the market landscape and its growth prospects over the
coming years. The report also includes a discussion of the key vendors
operating in this market.

The latest trend gaining momentum in the market is monetary growth among
consumers. Per capita disposable income exhibits low volatility in
developed countries because double-income households allow the users to
handle the additional expense with relative ease. The disposable income
is increasing globally, especially at a faster rate in developing
countries such as India, China, Brazil, Malaysia, Indonesia, and Vietnam.

According to the report, one of the major drivers for this market is
higher occurrence of diabetes among men. The increasing number of
diabetes cases among men globally poses the risk of problems related to
bladder and changes in sexual function. This can cause damage to nerves
and small blood vessels.

Key vendors

  • ASKA Pharmaceutical
  • Halotech DNA
  • Merck Serono
  • Zydus Cadila Healthcare

Other prominent vendors

  • AbbVie
  • Apricus Biosciences
  • Aytu BioScience
  • Others

Key Topics Covered:

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction

PART 05: Market landscape

PART 06: Market segmentation by under-lying cause

PART 07: Market segmentation by technique

PART 08: Market segmentation by end-user

PART 09: Geographical segmentation

PART 10: Decision framework

PART 11: Market drivers

PART 12: Market trends

PART 13: Vendor landscape

PART 14: Key Vendor Analysis

PART 15: Appendix

For more information about this report visit http://www.researchandmarkets.com/research/glfrkq/global_male

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S.
Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related
Topics: Women’s
Health